Abel Hall, LLC Ovid Therapeutics Inc. Transaction History
Abel Hall, LLC
- $166 Billion
- Q1 2025
A detailed history of Abel Hall, LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Abel Hall, LLC holds 10,238 shares of OVID stock, worth $2,969. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,238Holding current value
$2,969% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OVID
# of Institutions
83Shares Held
41.5MCall Options Held
2.4KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$1.54 Million0.08% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$1.16 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$1.12 Million0.13% of portfolio
-
Madison Avenue Partners, LP New York, NY3.72MShares$1.08 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.11MShares$901,5460.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $20.4M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...